Showing 1 - 2 results of 2 for search 'Ian Laster', query time: 0.03s Refine Results
  1. 1
    Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies

    Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies by Marina Stasenko, Evan Smith, Oladapo Yeku, Kay J. Park, Ian Laster, Kwangkook Lee, Sven Walderich, Elizabeth Spriggs, Bo Rueda, Britta Weigelt, Dmitriy Zamarin, Thapi Dharma Rao, David R. Spriggs

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition

    Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition by Oladapo O. Yeku, Oladapo O. Yeku, Thapi Dharma Rao, Ian Laster, Artem Kononenko, Terence J. Purdon, Pei Wang, Ziyou Cui, Hong Liu, Renier J. Brentjens, David Spriggs, David Spriggs

    Published 2021-04-01
    Get full text
    Article

Search Tools: